Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2009
06/25/2009US20090162364 Apo-2 ligand
06/25/2009US20090162363 Pedf-r receptor and uses
06/25/2009US20090162358 Antigen binding proteins
06/25/2009US20090162350 Novel composition and methods for the treatment of immune related disease
06/25/2009US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides
06/25/2009US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
06/25/2009US20090162293 Methods and compositions for ultrasound imaging of apoptosis
06/25/2009US20090162285 Anti-inflammatory fusion protein
06/25/2009US20090162278 Method for Production of Radioisotope Preparations and Their Use in Life Science, Research, Medical Application and Industry
06/25/2009US20090161828 Isolated phospholipid-protein particles
06/25/2009DE202005021713U1 Rekombinante Spinnenseidenproteine Recombinant spider silk proteins
06/25/2009DE102007062962A1 Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) New surface protein mutant of hepatitis B virus HBV surface antigen (HBsAg)
06/25/2009CA2709463A1 Trail variants for treating cancer
06/25/2009CA2708167A1 Vaccine antigens from piscirickettsia salmonis
06/25/2009CA2708093A1 Lipid metabolism protein and uses thereof i (bzip transcription factor)
06/25/2009CA2707771A1 Polypeptides having xylanase activity and polynucleotides encoding same
06/25/2009CA2707309A1 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
06/25/2009CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
06/24/2009EP2073013A1 Method of identifying transmembrane protein-interacting compounds
06/24/2009EP2072619A1 Factor involved in metastasis and uses thereof
06/24/2009EP2072529A1 MHC rapid assay used for the customization of odours
06/24/2009EP2072528A1 A host cell deficient for MuRF1 and MuRF2
06/24/2009EP2072527A1 Fusion polypeptides comprising a SHBG dimerization component and uses thereof
06/24/2009EP2072525A1 New polypeptides having affinity for HER2
06/24/2009EP2072058A1 Modified influenza virus
06/24/2009EP1987161A4 Method to identify cd40-sensitive cells
06/24/2009EP1801119B1 Interleukin-15 antagonist peptide
06/24/2009EP1709447B1 Method for detecting feline immunodeficiency virus
06/24/2009EP1651246A4 Method for promoting bone growth
06/24/2009EP1546090B1 Method for producing acylated peptides
06/24/2009EP1451333B1 Ul16 binding protein 4
06/24/2009EP1429650B1 Alternatively spliced circulating tissue factor
06/24/2009EP1397035B1 Method for modifying a plant phenotype
06/24/2009EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it
06/24/2009EP0943009B1 Species-specific, genus-specific and universal dna probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
06/24/2009CN101466732A Collagen type IV-like immunoreactive peptide
06/24/2009CN101466731A Antimicrobial linear peptides
06/24/2009CN101466730A A process for the preparation of poly-alfa-glutamic acid andderivatives thereof
06/24/2009CN101463081A GLP-1 derivative
06/24/2009CN101463080A Method for purifying nesiritide
06/24/2009CN101463079A Calf chondroprotein, preparation and use thereof
06/24/2009CN101463078A Exendin-4 derivative and solid phase chemical synthesis thereof
06/24/2009CN101463077A Synthetic single-zinc finger protein, two-zinc finger protein and four-zinc finger protein
06/24/2009CN100504392C Method of screening compounds that inhibit the biosynthesis of GPI in malaria parasites
06/24/2009CN100503829C Interleukin-18 mutants, their production and use
06/24/2009CN100503826C Recombined PDGF, its coding genes and expression method
06/24/2009CN100503823C DNA fragments containing gene having function relating to autonomous proliferation of plasmid
06/24/2009CN100503638C Protein tau
06/24/2009CN100503637C Glucagon-like peptide analog, its composition and its using method
06/24/2009CN100503636C Plant dehydration response element conjugated protein, its coding gene and application
06/24/2009CN100503635C Crystal of human avidin protein and preparation thereof
06/23/2009USRE40789 Mammalian checkpoint proteins polypeptides and encoding sequences thereof
06/23/2009USRE40786 IMMUNOSTIMULAnts COMPOSITION COMPRISING IMMUNOGENIC SUBSTANCE ENCAPSULATED IN POLYLACTIDE-CO-GLYCOLIDE MATRIX; vaccine for HIV-1
06/23/2009US7550657 Inbred maize line PHANF
06/23/2009US7550648 Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein
06/23/2009US7550647 Transfected shrimp as production systems for therapeutic proteins
06/23/2009US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents
06/23/2009US7550578 Rice promoters for regulation of plant expression
06/23/2009US7550574 Expression vector comprising nucleotide sequences coding membrane protein associated with odor preception (OR83B) for use in designing and/or identifying modulators of insect behavior; biolgical pest control
06/23/2009US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects
06/23/2009US7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen
06/23/2009US7550567 Contaminating proteins are depleted by negative chromatography and/or negative adsorption using cation exchanger, hydrophobic gel and/or dye gel; improved stability; fibrin glue
06/23/2009US7550566 G-CSF conjugates
06/23/2009US7550565 G-CSF conjugates
06/23/2009US7550564 DdrA protein; used to decrease exonuclease damage in DNA in relation to natural exonuclease damage that would occur in its absence
06/23/2009US7550563 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain
06/23/2009US7550562 Having pathogenic activity that can induce pemphigus lesion; a peptide specifically recognized by the monoclonal antibody and useful as a therapeutic drug for pemphigus autoimmune disease; drug screening
06/23/2009US7550561 Inhibitor of cell cycle progression; cell growth inhibitors; specifically binds a cyclin dependent kinase (cdk);
06/23/2009US7550438 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease
06/23/2009US7550435 Administering isolated omentin polypeptides that selectively express in omental fat tissue, promoting glucose uptake by animal adipocytes
06/23/2009US7550434 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis
06/23/2009US7550432 Recombinant fusion proteins to growth hormone and serum albumin
06/23/2009US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents
06/23/2009US7550427 Poly-pegylated protease inhibitors
06/23/2009US7550426 Acetylated therapeutic procytotoxins
06/23/2009US7550425 Diuretic peptide conjugates
06/23/2009US7550423 Modulate hormone release; controlling neurotransmitter release
06/23/2009US7550293 Chimeric nicotinic receptor subunits
06/23/2009US7550275 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide
06/23/2009US7550272 Method for diagnosis of pancreatic exocrine function
06/23/2009US7550263 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer
06/23/2009US7550262 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder
06/23/2009US7550257 Hyperpolarizing with potential-sensitive fluorescent dye and isoosmolar sodium-ion-free buffer, incubating, determining membrane potential, adding sodium, recording change in potential; voltage sensitive oxonol dyes; sodium channel modulators; high throughput screening; fluorescent imaging plate reader
06/23/2009US7550159 For treatment of cancer and autoimmune diseases; kits
06/23/2009US7550154 encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface; tissue engineering matrices, wound dressings, bone repair or regeneration materials
06/23/2009US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/23/2009CA2373466C Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh)
06/23/2009CA2330254C Nutritional assessment by measuring mitochondrial complex activity
06/23/2009CA2286395C Production method of heterologous protein
06/23/2009CA2226101C Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products
06/23/2009CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
06/21/2009CA2647856A1 Diagnostic test for cardiomyopathy
06/21/2009CA2647712A1 Poplar transcription factors
06/21/2009CA2612655A1 Poplar transcription factor myb134
06/19/2009CA2671983A1 Uses of cerberus, coco and derivatives thereof
06/18/2009WO2009076672A1 Advantageous salts of mu-opiate receptor peptides
06/18/2009WO2009076581A1 Fluctuations in amyloid beta as a biomarker for alzheimer's disease
06/18/2009WO2009076388A2 Targeting vector-phospholipid conjugates
06/18/2009WO2009076226A1 Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use
06/18/2009WO2009075954A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression